author

 
Menu
Search
 
April 25, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

Meta

James Paton
For James Paton's latest contributions to The Japan Times, see below:
Japan Times
WORLD / Science & Health
Feb 12, 2022
The era of pandemic restrictions is fast coming to an end
While the world has changed since early 2020 and new approaches to restrictions are justified, health officials warn that the coronavirus remains part of our reality.
Japan Times
BUSINESS
Dec 17, 2021
Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows
Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.
Japan Times
WORLD / Science & Health
Dec 3, 2021
Omicron accelerates push for second-generation COVID-19 shots
Experts say it is critical to invest in a variety of approaches, including inoculations that could target multiple versions of the pathogen in a single shot.
Japan Times
WORLD
Oct 14, 2021
Rush to buy Merck’s COVID-19 pill risks leaving poor countries behind
Despite efforts to license molnupiravir to generic-drug firms, the same risks of unequal distribution remain, says report.
Japan Times
WORLD / Science & Health
Sep 9, 2021
COVAX vaccine shortfall puts pressure on rich nations to act
A year ago, scores of countries committed to COVAX, the program set up to deliver COVID-19 vaccines equitably to every corner of the planet. Now the initiative is falling short of its goals.
Japan Times
WORLD / Science & Health
Sep 5, 2021
By the end of the year, wealthy nations will have 1.2 billion vaccine doses they don’t need
Wealthy countries face mounting pressure to divert COVID-19 vaccine supplies to lower-income regions.
Japan Times
WORLD
Jul 28, 2021
A pandemic-weary world is facing a distressing reality check
Around the globe, people and governments are finding out that COVID-19 won't be thrashed into extinction, but is more likely to enter a long, endemic tail.
Japan Times
WORLD
May 13, 2021
Wealthy nations’ vaccine spree obscures global pandemic misery
As India grapples with a deadly surge among its population of 1.4 billion, worries are growing for many other spots all over the planet.
Japan Times
ASIA PACIFIC
May 7, 2021
The world turns to China for vaccines after India and U.S. stumble
Some experts are worried about the potential impact of widely deploying Chinese shots that have demonstrated lower efficacy rates than those made by Pfizer and Moderna.
Japan Times
WORLD
Apr 8, 2021
AstraZeneca clot worries complicate bid to vaccinate the world
Reviews by U.K. and European Union regulators finding potential links to the unusual side effects are another blow for the shot.
Japan Times
WORLD
Feb 28, 2021
U.K.’s variant trackers led the way. Now others are following.
The COVID-19 Genomics U.K. Consortium has become a global model for analyzing genomes for signs that the coronavirus is gaining power to spread — or to kill.
Japan Times
WORLD / Science & Health
Feb 14, 2021
Spread of variants sparks push for all-in-one COVID-19 vaccines
Dangerous coronavirus variants are carpeting the globe, pushing scientists in the U.K. and elsewhere to target multiple versions of the pathogen in a single shot.
Japan Times
WORLD / Science & Health
Jan 19, 2021
Vaccine disparities raise alarm as coronavirus variants multiply
Global gaps in access to vaccines are raising concerns that the spread of the virus will breed more dangerous versions of the pathogen, weakening medical weapons.
Japan Times
WORLD / Science & Health
Dec 21, 2020
Vaccines don’t mean we’ll see the last of COVID-19, experts warn
Even with the latest technologies, money and might behind the unprecedented global drive to knock out COVID-19, the disease is unlikely to be eliminated any time soon.
Japan Times
WORLD / Science & Health
Nov 17, 2020
How the Moderna and Pfizer coronavirus vaccines stack up
The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.
Japan Times
WORLD / FOCUS
Oct 19, 2020
Getting vaccine doubters to roll up their sleeves won’t be easy
Fading trust in governments, political interference and the dash to create a shot in record time are sowing doubts.
Japan Times
WORLD / Science & Health / FOCUS
Aug 26, 2020
Developing countries don’t want to wait for superpowers’ vaccines
After COVID-19’s emergence in Buenos Aires led to a strict lockdown in March, Juliana Cassataro and her fellow vaccine researchers grew concerned. The U.S., Europe and China had already revved up their quests to obtain shots; how far back in line would Argentina have to wait for supplies?
Japan Times
WORLD / Science & Health
Aug 2, 2020
When it comes to COVID-19 vaccines, rich nations are first in line
Wealthy countries have already locked up more than a billion doses of coronavirus vaccines, raising worries that the rest of the world will be at the back of the queue in the global effort to defeat the pathogen.
Japan Times
WORLD / Politics / FOCUS
May 17, 2018
How Trump's fix-it man became $1.2 million headache for Novartis
When Michael Cohen showed up at Novartis AG last year proposing to help the drugmaker navigate the Donald Trump administration, it sounded like a promising opportunity. Cohen had, after all, served as an attorney for Trump and had close ties to the new president.
Japan Times
BUSINESS / Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever.
'Sugar Baby Riri' gets nine-year prison term over romance scam
Mai Watanabe, who went by the moniker “Sugar Baby Riri,” dated older men and swindled them out of money by telling them fictitious heartbreaking stories about herself to gain their sympathy.
Tokyo issues strong warning on yen intervention as currency dips further
Finance Minister Shunichi Suzuki speaks during a meeting with U.S. Treasury Secretary Janet Yellen and South Korean Finance Minister Choi Sang-mok on the sidelines of IMF and G20 meetings in Washington last week.
Japan’s cannabis market growing rapidly amid regulatory shift
The legality of products that contain cannabinoids, a group of substances derived from the cannabis plant, has been somewhat murky in Japan.
North Korean animators may be involved in Japan anime production, report says
North Korean animators may be involved in the production of some Japanese and U.S. animated shows, according to a report by a website providing analysis on North Korea.
BOJ to hold rates with focus on hawkish signals to buoy yen
Bank of Japan Gov. Kazuo Ueda hasn’t ruled out responding to exchange rates with a policy move if the impact on prices is seen to be "non-negligible.”
New workers name Shohei Ohtani as 'dream boss' for two years running
Shohei Ohtani has been overwhelmingly voted as the “dream boss” for people who started working in April, according to a survey.
A craft beer crawl through Tokyo’s top bars, brewpubs and dives
If all you drink is Asahi, Sapporo and Kirin, you're depriving yourself of some of the best craft beer Tokyo has to offer — and there sure is a lot of it out there.
'Sugar Baby Riri' gets nine-year prison term over romance scam
Mai Watanabe, who went by the moniker “Sugar Baby Riri,” dated older men and swindled them out of money by telling them fictitious heartbreaking stories about herself to gain their sympathy.
Tsukiji 2030s: A stadium, culinary center and transportation hub
A computer-generated image shows redevelopment plans for the former site of the Tsukiji fish market in Tokyo.
Hearing the impact of climate change in Okinawa, one bird call at a time
Toshihiro Kinjo (center), a research support technician at the Okinawa Institute of Science and Technology, inspects an audio recording device in Ginowan, Okinawa Prefecture, on April 3 as Masako Ogasawara, a research support specialist at OIST, looks on.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Later this month, author Shogo Imamura will open Honmaru, a bookstore that allows other businesses to rent its shelves. It's part of a wave of ideas Japanese booksellers are trying to compete with online spaces.
The story isn't over for Japan's bookstores
By Alex K.T. Martin

SUSTAINABLE JAPAN

Prize winner Maki Imoto catches light with glass
Prize winner Maki Imoto catches light with glass

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER